Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,016 | -3,880 | -9,303 | -21,800 | -19,959 |
| Depreciation Amortization | 599 | 1,291 | 1,521 | 1,739 | 207 |
| Accounts payable and accrued liabilities | 14 | 389 | -130 | 154 | -242 |
| Other Working Capital | -6,717 | -7,525 | -13,647 | 19,678 | -667 |
| Other Operating Activity | 2,915 | 4,018 | 2,011 | 1,059 | 531 |
| Operating Cash Flow | $-15,205 | $-5,707 | $-19,548 | $830 | $-20,130 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -41,037 | -52,175 | -106,618 | -128,324 | -22,857 |
| PPE Investments | -43 | -59 | -65 | -318 | -259 |
| Sale Of Investment | 46,250 | 53,500 | 122,751 | 95,307 | 45,554 |
| Other Investing Activity | 0 | 0 | 0 | 47,987 | 0 |
| Investing Cash Flow | $5,170 | $1,266 | $16,068 | $14,652 | $22,438 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -3,353 | -3,640 |
| Common Stock Issued | 38,744 | 1,380 | 169 | 470 | 68 |
| Financing Cash Flow | $38,744 | $1,380 | $169 | $-2,883 | $-3,572 |
| Beginning Cash Position | 10,659 | 13,720 | 17,031 | 4,432 | 5,696 |
| End Cash Position | 39,368 | 10,659 | 13,720 | 17,031 | 4,432 |
| Net Cash Flow | $28,709 | $-3,061 | $-3,311 | $12,599 | $-1,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,205 | -5,707 | -19,548 | 830 | -20,130 |
| Capital Expenditure | -43 | -59 | -65 | -318 | -259 |
| Free Cash Flow | -15,248 | -5,766 | -19,613 | 512 | -20,389 |